Hagar Lavon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hagar Lavon has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Mara H. Sherman
Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, USA
1 shared publication - Ruth Scherz-Shouval
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication Sneha Pramod
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 20 April 2026
- Published by Springer Nature in Nature Cancer
Heterogeneity and plasticity of cancer-associated fibroblasts
Fibroblasts sense and respond to contextual cues to support tissue structure and function. In cancer, they engage a dysregulated wound-healing response that profoundly shapes tumor composition and progression. Efforts to therapeutically target these cancer-associated fibroblasts (CAFs) have been complicated by their heterogeneity and plasticity. However, recent advances, particularly in single-cell and spatial technologies, have greatly improved the understanding of the phenotypic consequences of distinct CAF states and functions. Here we review the current understanding of CAFs as heterogeneous, instructive regulators of tumor microenvironments across anatomic sites and highlight key challenges for the future.
- 20 April 2026
- Published by Springer Nature in Nature Cancer
Top Cited PapersHeterogeneity and plasticity of cancer-associated fibroblasts
Fibroblasts sense and respond to contextual cues to support tissue structure and function. In cancer, they engage a dysregulated wound-healing response that profoundly shapes tumor composition and progression. Efforts to therapeutically target these cancer-associated fibroblasts (CAFs) have been complicated by their heterogeneity and plasticity. However, recent advances, particularly in single-cell and spatial technologies, have greatly improved the understanding of the phenotypic consequences of distinct CAF states and functions. Here we review the current understanding of CAFs as heterogeneous, instructive regulators of tumor microenvironments across anatomic sites and highlight key challenges for the future.